MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    The influence of neurorehabilitation on Parkinson medication

    V. Tomantschger, A. Tautscher-Basnett, M. Freimueller (Hermagor, Austria)

    Objective: To investigate the influence of neurorehabilitation on the dose changes of Parkinson medication over time.  Background: In progressive disorders such as Parkinson’s disease (PD),…
  • 2017 International Congress

    Low frequency Deep Brain stimulation for Parkinson’s disease – Effect on freezing of gait.

    R. Gopalakrishnan, G. Hosurkar (Bangalore, India)

    Objective: Parkinson's disease patients who have undergone deep brain stimulation ( DBS) having freezing of gait do not show improvement with high frequency stimulation (…
  • 2017 International Congress

    Direct dopaminergic responsiveness of activity performance

    P. Hagell, G.-M. Hariz, B. Sandlund (Kristianstad, Sweden)

    Objective: To assess the direct dopaminergic responsiveness of motor and process aspects of activity performance in people with parkinsonian disorders, and to compare this to…
  • 2017 International Congress

    Treadmill training, Tai Chi, dance and more: a meta-analysis on the effectiveness of different physiotherapy modalities in Parkinson’s disease

    D. Radder, N. de Vries, M. Faber, M. van Nimwegen, S. Keus, B. Bloem (Nijmegen, Netherlands)

    Objective: Physiotherapy (PT) is widely recognized as an intervention for people with Parkinson’s disease (PD). Many controlled trials have evaluated conventional PT, and the evidence…
  • 2017 International Congress

    Design and discovery of 1,2,4 triazole derivatives as adenosine A2A receptor antagonist against parkinson’s disease

    A. Verma, V. Kumar, U. Singh (Allahabad, India)

    Objective: In the present study, we intended to develop novel 1,2,4 triazole as potent A(2A)AR antagonists against parkinson’s disease. Background: Parkinson’s disease (PD) is a…
  • 2017 International Congress

    Alternative Apomorphine Challenge Test

    J.C. Martinez Castrillo, A. Alonso Canovas, C. Estevez Fraga, G. Sanchez Diez, I. Avilés Olmos, J. Lopez Sendon, P. Garcia Ruiz, L. Vela Desojo (Madrid, Spain)

    Objective: To propose a new apomorphine challenge test Background: In the standard apomorphine challenge test, the appropriate dose of apomorphine is established by incremental dosing…
  • 2017 International Congress

    Neuroprotection and Alleviation of Parkinsonian Phenotypes by Ayurvedic Herbs

    S. Singh, J. Prakash, S. Yadav (Varanasi, India)

    Objective: Our laboratory has focused on the herbal treatment of Parkinson’s disease especially by the above two common herbs Withania somnifera (Ws) and Mucuna pruriens…
  • 2017 International Congress

    Effects of non-invasive electrical and magnetic stimulation to improve motor and cognitive function in Parkinson’s disease: a meta-analytical review

    A. Goodwill, J. Lum, A. Hendy, M. Muthalib, L. Johnson, N. Albein-Urios, W.-P. Teo (Burwood, Australia)

    Objective: This meta-analytical review aims to compare 1) the effects of non-invasive repetitive transcranial magnetic (rTMS) and transcranial electrical stimulation (tES); and 2) identify optimal…
  • 2017 International Congress

    Istradefylline improves motor symptoms in Parkinson’s disease: A meta-analysis

    W. Sako, N. Murakami, K. Motohama, Y. Izumi, R. Kaji (Tokushima, Japan)

    Objective: The aim of this meta-analysis was to provide strong evidence for the main and side effects of istradefylline on patients with Parkinson’s disease. Background:…
  • 2017 International Congress

    Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm

    S. Pandey, S. Jain (New Delhi, India)

    Objective: To study demographic and clinical features of  primary and secondary hemifacial spasm and assess their response to botulinum toxin therapy. Background: Hemifacial spasm (HFS)…
  • « Previous Page
  • 1
  • …
  • 1260
  • 1261
  • 1262
  • 1263
  • 1264
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley